AKT1 and posterior cortical atrophy: As we discovered, KDM4C regulates the protein expression and phosphorylation of AKT and c-Myc as well as affects the AR transcriptional activity in PCa, and it is possible that KDM4C inhibitors may be beneficial for patients with PCa.